ACHN
Achillion Pharmaceuticals
ACHN
ACHN
Delisted
ACHN was delisted on the 27th of January, 2020.
179 hedge funds and large institutions have $1.08B invested in Achillion Pharmaceuticals in 2014 Q4 according to their latest regulatory filings, with 48 funds opening new positions, 53 increasing their positions, 58 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
11% more funds holding
Funds holding: 161 → 179 (+18)
9% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 58
Holders
179
Holding in Top 10
5
Calls
$126M
Puts
$64.1M
Top Buyers
| 1 | +$52.8M | |
| 2 | +$35.8M | |
| 3 | +$29.1M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$25.4M |
| 5 |
Goldman Sachs
New York
|
+$20.2M |
Top Sellers
| 1 | -$32.4M | |
| 2 | -$30.4M | |
| 3 | -$24.4M | |
| 4 |
Renaissance Technologies
New York
|
-$8.96M |
| 5 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
-$6.23M |